Evolution of repaired and non-repaired tricuspid regurgitation in rheumatic mitral valve surgery without severe pulmonary hypertension.
Kirali K, Omeroğlu SN, Uzun K, Erentuğ V, Bozbuğa N, Eren E, Balkanay M, Alp M, Yakut C.
Asian Cardiovasc Thorac Ann. 2004 Sep;12(3):239-45. doi: 10.1177/021849230401200313.
Isolated Tricuspid Valve Surgery: The Auckland Experience 2011-2019.
Singh N, Kim H, Haydock DA.
Heart Lung Circ. 2022 Apr;31(4):582-589. doi: 10.1016/j.hlc.2021.09.020. Epub 2021 Oct 26.
Outcome following acute and recurrent rheumatic fever.
Silvilairat S, Sornwai A, Sethasathien S, Saengsin K, Makonkawkeyoon K, Sittiwangkul R, Pongprot Y.
Paediatr Int Child Health. 2024 May;44(1):13-17. doi: 10.1080/20469047.2024.2313330. Epub 2024 Feb 16.
Clinical outcomes and progression rate of tricuspid regurgitation in patients with rheumatic mitral valve disease.
Caldas MMC, Esteves WAM, Nascimento BR, Hung J, Levine R, Silva VR, Castro ML, Chavez LMT, Silva JLPD, Mello LA, Ruffo FC, Andrade AB, Tan T, Passaglia LG, Freire CMV, Nunes MCP.
Open Heart. 2023 Sep;10(2):e002295. doi: 10.1136/openhrt-2023-002295.
Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes.
Kim JB, Yoo DG, Kim GS, Song H, Jung SH, Choo SJ, Chung CH, Lee JW.
Heart. 2012 Jan;98(1):24-30. doi: 10.1136/heartjnl-2011-300403. Epub 2011 Sep 19.
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
Antunes MJ, Rodríguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar N, Barili F, Casselman F, Folliguet T, Iung B, Lancellotti P, Muneretto C, Obadia JF, Pierard L, Suwalski P, Zamorano P; ESC Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1022-1030. doi: 10.1093/ejcts/ezx279.
Reoperation for acquired discrete subaortic membrane and multivalvular dysfunction after mitral valve replacement.
Kahraman N, Binicier NA.
Indian J Thorac Cardiovasc Surg. 2025 Oct;41(10):1483-1487. doi: 10.1007/s12055-025-01995-8. Epub 2025 Jul 2.
Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
Huang X, Dhruva SS, Yuan X, Bai X, Lu Y, Yan X, Liu J, Li W, Hu D, Ji R, Gao M, Miao F, Li J, Ge J, Krumholz HM, Li J.
BMJ Open. 2021 Nov 3;11(11):e052946. doi: 10.1136/bmjopen-2021-052946.
Surgical repair for degenerative and rheumatic mitral valve disease. Operative and mid-term results.
Piciché M, El Khoury G, D'udekem D'akoz Y, Noirhomme P.
J Cardiovasc Surg (Torino). 2002 Jun;43(3):327-35.
Clinical correlates and mortality of hemodynamically significant tricuspid regurgitation.
Behm CZ, Nath J, Foster E.
J Heart Valve Dis. 2004 Sep;13(5):784-9.
